Andrew Rock is a serial entrepreneur and has spent his entire career within the global medical technology industry. Mr Rock was a former co-founder of K2M Group (acquired by Stryker for $1.4B), has served as a member of the Executive Management Team at American Osteomedix and Chairman and CEO of Rock Surgical Associates, and has developed over 18 utility and method patents for the treatment of complex spine pathologies.
Currently, Mr. Rock is the founder and managing partner of Neuro Spine Ventures LLC (“NSV”), a 52-member global angel investor group which has produced returns on investment ranging from 85% to 3,008%, not including 2 recent successful exits to SeaSpine and NuVasive. Mr. Rock also is Co-Founder and Executive Director of DP Enterprises Group Inc., which provides product development and global marketing services for med-tech companies, and serves on the Board of Directors for several corporations, including Syracuse-based Quadrant Biosciences, Inc; Minneapolis-based St Teresa Medical Inc.; and Indianapolis-based Recovery Force, LLC.
Mr. Rock received his degrees from Linsly and West Virginia University.